Zydus Lifesciences Ltd stated that the Mexican regulatory authority has approved the marketing of Mamitra, a Trastuzumab biosimilar for treating different cancer types. Mamitra is utilized for treating breast cancer as well as advanced stomach...
Boehringer Ingelheim, a biopharmaceutical company involved in human and animal health, revealed the addition of a new preclinical program through the purchase of Nerio Therapeutics Inc. for a maximum of USD 1.3 billion. Boehringer Ingelheim hopes...
Roche confirmed the finalization of the acquisition of LumiraDx’s Point of Care technology after obtaining all necessary antitrust and regulatory approvals. Roche will now start the complete merging of the company's advanced multi-assay point of...
The consolidated financial results of Strides Pharma Science for Q1FY25 ended June 30, 2024 show revenues of Rs.1,087.5 crore, compared to Rs. from the same quarter last year. 9,320 crore showing an increase of 16.75 percent compared to the...
Innovent Biologics, Inc. (Innovent), a top biopharmaceutical company creating high-quality medications for various diseases, has revealed a collaboration with WeComput to enhance Innovent Biologics’ Artificial Intelligence for Drug Discovery...
Cosmetics Ingredients Conference promises to be the focal point of innovation, education, and networking in the beauty and personal care industry. Taking place on 30-31 August 2024 in Chennai Trade Centre, Nandambakkam, Chennai and themed.
IASO Biotechnology (IASO Bio) has disclosed that the National Medical Products Administration (NMPA) has granted approval for the investigational new drug (IND) application for IASO-782 Injection, a fully human monoclonal antibody targeting human...
BioMarin Pharmaceutical Inc. declared that the FDA has given the green light to the company's sBLA for Brineura to help delay the loss of walking ability in children with CLN2 disease, also known as TPP1 deficiency. Before, Brineura was approved...
UK MHRA has provided the approval to a modified Pfizer/BioNTech Covid-19 vaccine (Comirnaty) designed for the JN.1 Covid-19 subvariant. The vaccine stimulates the immune system to generate antibodies and blood cells to combat Covid-19...
Neuroscience Inc., a company focused on advancing in neuroscience, revealed that the initial patient has received medication in the RECONNECT phase 2 trial of RE104 for postpartum depression (PPD) treatment. RE104 was created with the intention of...
, CDSCO.jpg)
.jpg)